Thermo Fisher Scientific Inc. (TMO) Shares Sold by Korea Investment CORP
Korea Investment CORP cut its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 415,676 shares of the medical research company’s stock after selling 6,700 shares during the quarter. Korea Investment CORP owned approximately 0.10% of Thermo Fisher Scientific worth $93,024,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Hanson McClain Inc. boosted its stake in Thermo Fisher Scientific by 263.9% during the fourth quarter. Hanson McClain Inc. now owns 131 shares of the medical research company’s stock worth $29,000 after acquiring an additional 95 shares in the last quarter. Capital Investment Advisory Services LLC bought a new position in Thermo Fisher Scientific during the fourth quarter worth $35,000. Gradient Investments LLC boosted its stake in Thermo Fisher Scientific by 1,887.5% during the fourth quarter. Gradient Investments LLC now owns 159 shares of the medical research company’s stock worth $36,000 after acquiring an additional 151 shares in the last quarter. WESPAC Advisors SoCal LLC boosted its stake in Thermo Fisher Scientific by 70.0% during the fourth quarter. WESPAC Advisors SoCal LLC now owns 170 shares of the medical research company’s stock worth $38,000 after acquiring an additional 70 shares in the last quarter. Finally, Doyle Wealth Management bought a new position in Thermo Fisher Scientific during the fourth quarter worth $38,000. 87.11% of the stock is currently owned by institutional investors and hedge funds.
Several research analysts recently issued reports on TMO shares. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $270.00 target price on the stock in a research note on Thursday, December 13th. BTIG Research raised their price objective on shares of Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a research note on Thursday, January 31st. Needham & Company LLC began coverage on shares of Thermo Fisher Scientific in a research note on Wednesday, January 2nd. They issued a “strong-buy” rating and a $271.00 price objective on the stock. Finally, Barclays raised their price objective on shares of Thermo Fisher Scientific from $275.00 to $280.00 and gave the company an “overweight” rating in a research note on Thursday, January 3rd. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $275.70.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, January 30th. The medical research company reported $3.25 earnings per share for the quarter, beating analysts’ consensus estimates of $3.19 by $0.06. Thermo Fisher Scientific had a net margin of 12.06% and a return on equity of 16.86%. The firm had revenue of $6.51 billion for the quarter, compared to analyst estimates of $6.26 billion. During the same period last year, the firm earned $2.79 earnings per share. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities research analysts predict that Thermo Fisher Scientific Inc. will post 12.14 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 16th. Shareholders of record on Friday, March 15th will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.29%. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Thursday, March 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 6.12%.
In other news, SVP Gregory J. Herrema sold 5,400 shares of the stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $251.51, for a total value of $1,358,154.00. Following the completion of the sale, the senior vice president now owns 31,846 shares in the company, valued at $8,009,587.46. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Gregory J. Herrema sold 19,808 shares of the stock in a transaction dated Monday, February 25th. The shares were sold at an average price of $253.29, for a total transaction of $5,017,168.32. Following the completion of the sale, the senior vice president now owns 25,688 shares of the company’s stock, valued at approximately $6,506,513.52. The disclosure for this sale can be found here. Insiders sold 36,927 shares of company stock worth $9,388,124 over the last ninety days. Insiders own 0.49% of the company’s stock.
WARNING: “Thermo Fisher Scientific Inc. (TMO) Shares Sold by Korea Investment CORP” was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.watchlistnews.com/thermo-fisher-scientific-inc-tmo-shares-sold-by-korea-investment-corp/2895841.html.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Featured Article: What is the Difference Between Common Shares and Convertible Shares?
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.